Off-Label Communications: Industry, FDA Debate Role Of Peer Review
Executive Summary
Allowing manufacturers to share research on unapproved uses that has not been formally vetted and published raises transparency concerns, US FDA commissioner says; industry attorney counters that many useful data sources 'would never see the light of day' under current peer review approaches.